The Klinique Med Stock Current Liabilities
| KLINIQ Stock | 31.00 0.50 1.64% |
The Klinique Med fundamentals help investors to digest information that contributes to Klinique Med's financial success or failures. It also enables traders to predict the movement of Klinique Stock. The fundamental analysis module provides a way to measure Klinique Med's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Klinique Med stock.
Klinique |
The Klinique Med Company Current Liabilities Analysis
Klinique Med's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, The Klinique Med has a Current Liabilities of 0.0. This is 100.0% lower than that of the Consumer Cyclical sector and 100.0% lower than that of the Personal Services industry. The current liabilities for all Thailand stocks is 100.0% higher than that of the company.
Klinique Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Klinique Med's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Klinique Med could also be used in its relative valuation, which is a method of valuing Klinique Med by comparing valuation metrics of similar companies.Klinique Med is currently under evaluation in current liabilities category among its peers.
Klinique Fundamentals
| Return On Equity | 0.95 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 9.44 B | |||
| Shares Outstanding | 220 M | |||
| Shares Owned By Insiders | 73.66 % | |||
| Price To Book | 39.18 X | |||
| Price To Sales | 5.73 X | |||
| Revenue | 1.49 B | |||
| Gross Profit | 558.77 M | |||
| EBITDA | 288.81 M | |||
| Book Value Per Share | 0.95 X | |||
| Earnings Per Share | 1.09 X | |||
| Target Price | 44.5 | |||
| Market Capitalization | 7.81 B | |||
| Last Dividend Paid | 0.43 |
About Klinique Med Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The Klinique Med's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Klinique Med using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The Klinique Med based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Klinique Stock
Klinique Med financial ratios help investors to determine whether Klinique Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Klinique with respect to the benefits of owning Klinique Med security.